A review of psychosocial issues in patients with chronic hepatitis B

Amirhossein Modabbernia1, Mandana Ashrafi, Reza Malekzadeh

  • 1Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Chronic hepatitis B (CHBV) significantly impacts patients' health-related quality of life (HRQOL) and mental well-being. Interventions and psycho-education can improve HRQOL, while more research is needed on stigma and coping strategies.

Area of Science:

  • Hepatology
  • Psychiatry
  • Public Health

Background:

  • Psychosocial issues and health-related quality of life (HRQOL) are crucial in managing chronic hepatitis B (CHBV).
  • Understanding these factors is essential for comprehensive patient care.

Purpose of the Study:

  • To review and categorize existing literature on HRQOL, mental health, and psychosocial issues in CHBV patients.
  • To identify gaps in research regarding interventions, stigma, and coping mechanisms.

Main Methods:

  • Systematic literature search of Medline, ISI Web of Knowledge, Google Scholar, and AASLD website until January 2012.
  • Content categorized into HRQOL, mental health, and psychosocial issues (stigma, coping).

Main Results:

  • Increasing CHBV severity and cirrhosis negatively impact HRQOL; treatment and psycho-education show improvement.
  • Mood disorders may be more frequent in CHBV patients; alcohol and low social support are detrimental.
  • CHBV patients generally fare better in HRQOL and mental health than hepatitis C (HCV) patients; stigma requires further investigation.

Conclusions:

  • HRQOL and mental health are significantly affected in CHBV, especially in severe cases.
  • Intervention studies for psychosocial problems in CHBV are limited.
  • Further research is needed on stigma, coping, and psychosomatic disorders in CHBV.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...